Profound Medical Corp.
PROF
$6.19
-$0.11-1.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.49% | 49.18% | -46.35% | -116.78% | 47.18% |
| Total Depreciation and Amortization | -25.85% | 4.26% | -13.50% | -31.51% | 11.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -17.40% | 15.44% | 40.47% | 104.78% | -24.40% |
| Change in Net Operating Assets | 103.56% | -1,043.17% | -70.72% | 174.76% | -200.66% |
| Cash from Operations | 31.70% | 30.05% | -65.93% | -40.89% | 13.87% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 60.86% | -25.17% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 100.00% | -100.82% | 6,085.64% |
| Foreign Exchange rate Adjustments | 136.69% | -130.13% | 2,565.96% | 105.32% | -482.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 436.55% | 7.73% | -32.54% | -130.51% | 499.50% |